• Issue

    Journal of Viral Hepatitis: Volume 28, Issue 7

    973-1100
    July 2021
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 973-975
  • First Published: 18 June 2021

REVIEW

Open Access

Clinical and occupational health management of healthcare workers living with chronic hepatitis B: UK policy and international comparisons

Grace E. Dolman,  Apostolos Koffas,  Emily Phipps,  Patrick T.F. Kennedy, 
  • Pages: 976-981
  • First Published: 04 March 2021

ORIGINAL ARTICLES

Willingness to participate in research among black patients with liver disease: A national cross-sectional study

F. Hunter McGuire,  Kat André,  Minyone L. Bradsher,  Dawn Harrison,  Richard K. Sterling,  K. Rajender Reddy,  Marina Serper,  Carol E. Golin,  Nancy Reau,  Joseph K. Lim,  David R. Nelson,  Souvik Sarkar,  Donna M. Evon, 
  • Pages: 982-993
  • First Published: 04 March 2021
Open Access

Progress on the elimination of viral hepatitis in Zimbabwe: A review of the policies, strategies and challenges

Blessing Dzingirai,  Leolin Katsidzira,  Celia Moffat Joel Matyanga,  Maarten Jacobus Postma,  Marinus van Hulst,  Nyashadzaishe Mafirakureva, 
  • Pages: 994-1002
  • First Published: 02 April 2021

Clinical utility of quantifying hepatitis B surface antigen in African patients with chronic hepatitis B

Gerrit Post,  Jess Howell,  Amina Sow,  Gibril Ndow,  Isabelle Chemin,  Gora Lo,  Amie Cessay,  Damien Cohen,  Ramou Njie,  Souleymane Toure,  Madoky Diop,  Roger Sombie,  Jean Nana,  Vincent Leroy,  Karine Lacombe,  Lamin Bojang,  Frank Tacke,  Coumba Toure-Kane,  Mourtalla Ka,  Maimuna Mendy,  Souleymane Mboup,  Mark Thursz,  Yusuke Shimakawa,  Patrick Ingiliz,  Maud Lemoine, 
  • Pages: 1003-1010
  • First Published: 22 March 2021

Effect of antiviral therapy in patients with low HBV DNA level on transarterial chemoembolization for hepatocellular carcinoma

Myung Pyo Kim,  Jae Kook Yang,  Baek Gyu Jun,  Young Don Kim,  Gab Jin Cheon,  Hee Jae Jung,  Jeong-Ju Yoo,  Sang Gyune Kim,  Young Seok Kim,  Soung Won Jeong,  Jae Young Jang,  Hong Soo Kim,  Sae Hwan Lee, 
  • Pages: 1011-1018
  • First Published: 24 March 2021

Efficacy of an accelerated double-dose hepatitis B vaccine regimen in patients with cirrhosis

Sergio Rodríguez-Tajes,  Anna Pocurull,  Sabela Lens,  Zoe Mariño,  Ignasi Olivas,  Guillem Soy,  Anna Alonso,  Anna Vilella,  Xavier Forns, 
  • Pages: 1019-1024
  • First Published: 24 March 2021

Distribution and clinical characteristics of patients with chronic hepatitis B virus infection in the grey zone

Kefang Yao,  Jiacheng Liu,  Jian Wang,  Xiaomin Yan,  Juan Xia,  Yue Yang,  Weihua Wu,  Yong Liu,  Yuxin Chen,  Zhaoping Zhang,  Jie Li,  Rui Huang,  Chao Wu, 
  • Pages: 1025-1033
  • First Published: 02 April 2021

Assessing risk scores for predicting hepatocellular carcinoma in Thai patients with chronic hepatitis B

Thanachote Kamalapirat,  Kesinee Yingcharoen,  Teerapat Ungtrakul,  Kamonwan Soonklang,  Jiraporn Dechma,  Pitchayachuda Chunnuan,  Pattama Kusuman,  Charinthip Pothijaroen,  Jantarika Tawpa,  Kunsuda Cheirsilpa,  Chirayu Auewarakul, 
  • Pages: 1034-1041
  • First Published: 20 April 2021

Clinical significance of quantitative e antigen in a cohort of hepatitis B virus-infected children and adults in North America

Stewart L. Cooper,  Wendy C. King,  Douglas B. Mogul,  Marc G. Ghany,  Kathleen B. Schwarz,  Hepatitis B Research Network (HBRN) , 
  • Pages: 1042-1056
  • First Published: 24 April 2021

Epidemiology estimates of hepatitis D in individuals co-infected with human immunodeficiency virus and hepatitis B virus, 2002–2018: A systematic review and meta-analysis

Dan-Ting Shen,  Pei-Chun Han,  Dong-Ze Ji,  Hai-Yan Chen,  Wei-Dong Cao,  Hemant Goyal,  Hua-Guo Xu, 
  • Pages: 1057-1067
  • First Published: 20 April 2021

Patient-reported outcomes of the Treatment and Prevention Study: A real-world community-based trial of direct-acting antivirals for hepatitis C among people who inject drugs

Stelliana Goutzamanis,  Timothy Spelman,  Brendan Harney,  Paul Dietze,  Mark Stoove,  Peter Higgs,  Alexander Thompson,  Joseph S. Doyle,  Margaret Hellard, 
  • Pages: 1068-1077
  • First Published: 20 April 2021

Variability in molecular characteristics of Hepatitis E virus quasispecies could modify viral surface properties and transmission

Cédric Hartard,  Honorine Fenaux,  Alexis Gentilhomme,  John M. Murray,  Elma Akand,  Elodie Laugel,  Sibel Berger,  Armand Maul,  Alexis de Rougemont,  Hélène Jeulin,  Thomas Remen,  Mouni Bensenane,  Jean-Pierre Bronowicki,  Christophe Gantzer,  Isabelle Bertrand,  Evelyne Schvoerer, 
  • Pages: 1078-1090
  • First Published: 20 April 2021

Assessment of subclinical effects of Hepatitis E virus infection in the United States

Chimaobi Anugwom,  Christopher Campbell,  Jose D. Debes, 
  • Pages: 1091-1097
  • First Published: 24 April 2021

LETTERS TO THE EDITOR

Comment on ‘Long-term prognosis with or without nucleot(s)ide analogue therapy in hepatitis B virus-related decompensated cirrhosis’

Fangbin Weng, 
  • Page: 1098
  • First Published: 19 April 2021

Reply to: ‘Long-term prognosis with or without nucleot(s)ide analogue therapy in hepatitis B virus-related decompensated cirrhosis’

Takashi Kumada, 
  • Pages: 1099-1100
  • First Published: 28 April 2021